136 related articles for article (PubMed ID: 37721536)
21. New structural insight of C-terminal region of Syntenin-1, enhancing the molecular dimerization and inhibitory function related on Syndecan-4 signaling.
Choi Y; Yun JH; Yoo J; Lee I; Kim H; Son HN; Kim IS; Yoon HS; Zimmermann P; Couchman JR; Cho HS; Oh ES; Lee W
Sci Rep; 2016 Nov; 6():36818. PubMed ID: 27830760
[TBL] [Abstract][Full Text] [Related]
22. PDZ tandem of human syntenin: crystal structure and functional properties.
Kang BS; Cooper DR; Jelen F; Devedjiev Y; Derewenda U; Dauter Z; Otlewski J; Derewenda ZS
Structure; 2003 Apr; 11(4):459-68. PubMed ID: 12679023
[TBL] [Abstract][Full Text] [Related]
23. Syntenin: PDZ Protein Regulating Signaling Pathways and Cellular Functions.
Shimada T; Yasuda S; Sugiura H; Yamagata K
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454940
[TBL] [Abstract][Full Text] [Related]
24. Inhibitors against Two PDZ Domains of MDA-9 Suppressed Migration of Breast Cancer Cells.
Tang H; Wang L; Li S; Wei X; Lv M; Zhong F; Liu Y; Liu J; Fu B; Zhu Q; Wang D; Liu J; Ruan K; Gao J; Xu W
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834839
[TBL] [Abstract][Full Text] [Related]
25. MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma.
Das SK; Bhutia SK; Azab B; Kegelman TP; Peachy L; Santhekadur PK; Dasgupta S; Dash R; Dent P; Grant S; Emdad L; Pellecchia M; Sarkar D; Fisher PB
Cancer Res; 2013 Jan; 73(2):844-54. PubMed ID: 23233738
[TBL] [Abstract][Full Text] [Related]
26. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S
PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
[TBL] [Abstract][Full Text] [Related]
27. MDA-9/syntenin is a key regulator of glioma pathogenesis.
Kegelman TP; Das SK; Hu B; Bacolod MD; Fuller CE; Menezes ME; Emdad L; Dasgupta S; Baldwin AS; Bruce JN; Dent P; Pellecchia M; Sarkar D; Fisher PB
Neuro Oncol; 2014 Jan; 16(1):50-61. PubMed ID: 24305713
[TBL] [Abstract][Full Text] [Related]
28. MDA-9/syntenin interacts with ubiquitin via a novel ubiquitin-binding motif.
Okumura F; Yoshida K; Liang F; Hatakeyama S
Mol Cell Biochem; 2011 Jun; 352(1-2):163-72. PubMed ID: 21359963
[TBL] [Abstract][Full Text] [Related]
29. Biological Role and Aberrant Overexpression of Syntenin-1 in Cancer: Potential Role as a Biomarker and Therapeutic Target.
Pintor-Romero VG; Hurtado-Ortega E; Nicolás-Morales ML; Gutiérrez-Torres M; Vences-Velázquez A; Ortuño-Pineda C; Espinoza-Rojo M; Navarro-Tito N; Cortés-Sarabia K
Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189651
[TBL] [Abstract][Full Text] [Related]
30. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma.
Das SK; Bhutia SK; Sokhi UK; Azab B; Su ZZ; Boukerche H; Anwar T; Moen EL; Chatterjee D; Pellecchia M; Sarkar D; Fisher PB
Cancer Res; 2012 Dec; 72(23):6217-26. PubMed ID: 23066033
[TBL] [Abstract][Full Text] [Related]
31. MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein.
Pradhan AK; Maji S; Das SK; Emdad L; Sarkar D; Fisher PB
Cancer Metastasis Rev; 2020 Sep; 39(3):769-781. PubMed ID: 32410111
[TBL] [Abstract][Full Text] [Related]
32. Melanoma metastasis is associated with enhanced expression of the syntenin gene.
Helmke BM; Polychronidis M; Benner A; Thome M; Arribas J; Deichmann M
Oncol Rep; 2004 Aug; 12(2):221-8. PubMed ID: 15254681
[TBL] [Abstract][Full Text] [Related]
33. Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma.
Notarbartolo M; Labbozzetta M; Pojero F; D'Alessandro N; Poma P
Curr Mol Med; 2018; 18(9):630-639. PubMed ID: 30608040
[TBL] [Abstract][Full Text] [Related]
34. MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasis.
Das SK; Sarkar D; Emdad L; Fisher PB
Adv Cancer Res; 2019; 144():137-191. PubMed ID: 31349898
[TBL] [Abstract][Full Text] [Related]
35. Frizzled 7 and PIP2 binding by syntenin PDZ2 domain supports Frizzled 7 trafficking and signalling.
Egea-Jimenez AL; Gallardo R; Garcia-Pino A; Ivarsson Y; Wawrzyniak AM; Kashyap R; Loris R; Schymkowitz J; Rousseau F; Zimmermann P
Nat Commun; 2016 Jul; 7():12101. PubMed ID: 27386966
[TBL] [Abstract][Full Text] [Related]
36. The tandem PDZ domains of syntenin promote cell invasion.
Meerschaert K; Bruyneel E; De Wever O; Vanloo B; Boucherie C; Bracke M; Vandekerckhove J; Gettemans J
Exp Cell Res; 2007 May; 313(9):1790-804. PubMed ID: 17451681
[TBL] [Abstract][Full Text] [Related]
37. Expression patterns of MDA-9/syntenin during development of the mouse embryo.
Jeon HY; Das SK; Dasgupta S; Emdad L; Sarkar D; Kim SH; Lee SG; Fisher PB
J Mol Histol; 2013 Apr; 44(2):159-66. PubMed ID: 23180153
[TBL] [Abstract][Full Text] [Related]
38. mda-9/syntenin: recent insights into a novel cell signaling and metastasis-associated gene.
Sarkar D; Boukerche H; Su ZZ; Fisher PB
Pharmacol Ther; 2004 Nov; 104(2):101-15. PubMed ID: 15518882
[TBL] [Abstract][Full Text] [Related]
39. The tandem PDZ protein Syntenin interacts with the aminoacyl tRNA synthetase complex in a lysyl-tRNA synthetase-dependent manner.
Meerschaert K; Remue E; De Ganck A; Staes A; Boucherie C; Gevaert K; Vandekerckhove J; Kleiman L; Gettemans J
J Proteome Res; 2008 Nov; 7(11):4962-73. PubMed ID: 18839981
[TBL] [Abstract][Full Text] [Related]
40. MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.
Maji S; Pradhan AK; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Windle JJ; Subler MA; Wang XY; Semmes OJ; Nyalwidhe JO; Mukhopadhyay N; Paul AK; Hatfield B; Levit MM; Madan E; Sarkar D; Emdad L; Cohen DJ; Gogna R; Cavenee WK; Das SK; Fisher PB
Proc Natl Acad Sci U S A; 2023 Nov; 120(45):e2307094120. PubMed ID: 37922327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
